Videos
Cadrenal Therapeutics (CVKD) Company Webcast
Cadrenal Therapeutics, Inc. is a biopharmaceutical company developing transformative therapeutics to address limitations of current anticoagulation therapy. This company webcast was recorded during the Lytham Partners Fall 2025 Investor Conference.
Cadrenal Therapeutics (CVKD) Fireside Chat
During this fireside chat we welcome Cadrenal Therapeutics (Nasdaq: CVKD). Cadrenal Therapeutics is developing tecarfarin for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) to prevent heart...
Cadrenal Therapeutics (CVKD) Fireside Chat
Cadrenal Therapeutics (Nasdaq: CVKD) is a late-stage biopharmaceutical company boldly challenging the status quo by innovating a new anticoagulant to elevate care for underserved patients. The company is developing the vitamin K antagonist (VKA) tecarfarin, designed...